Activated Protein C Cofactor Function of Protein S: a Critical Role for Asp95 in the EGF1-like Domain

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2010 Mar 24

PMID 20308596

Citations 15

Authors

Helena M Andersson

Marcia J Arantes

James T B Crawley

Brenda M Luken

Sinh Tran

Bjorn Dahlback

David A Lane

Suely M Rezende

Affiliations

Soon will be listed here.

Abstract

Protein S has an established role in the protein C anticoagulant pathway, where it enhances the factor Va (FVa) and factor VIIIa (FVIIIa) inactivating property of activated protein C (APC). Despite its physiological role and clinical importance, the molecular basis of its action is not fully understood. To clarify the mechanism of the protein S interaction with APC, we have constructed and expressed a library of composite or point variants of human protein S, with residue substitutions introduced into the Gla, thrombin-sensitive region (TSR), epidermal growth factor 1 (EGF1), and EGF2 domains. Cofactor activity for APC was evaluated by calibrated automated thrombography (CAT) using protein S-deficient plasma. Of 27 variants tested initially, only one, protein S D95A (within the EGF1 domain), was largely devoid of functional APC cofactor activity. Protein S D95A was, however, gamma-carboxylated and bound phospholipids with an apparent dissociation constant (Kd(app)) similar to that of wild-type (WT) protein S. In a purified assay using FVa R506Q/R679Q, purified protein S D95A was shown to have greatly reduced ability to enhance APC-induced cleavage of FVa Arg306. It is concluded that residue Asp95 within EGF1 is critical for APC cofactor function of protein S and could define a principal functional interaction site for APC.

Citing Articles

Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.

Yalcinkaya A, Cavalli M, Aranda-Guillen M, Cederholm A, Guner A, Rietrae I Sci Rep. 2024; 14(1):24512.

PMID: 39424883 PMC: 11489816. DOI: 10.1038/s41598-024-75514-x.

TFPIα anticoagulant function is highly dependent on protein S in vivo.

Petri A, Sasikumar P, Folgado P, Jones D, Xu Y, Ahnstrom J Sci Adv. 2024; 10(5):eadk5836.

PMID: 38306422 PMC: 11809661. DOI: 10.1126/sciadv.adk5836.

The first laminin G-like domain of protein S is essential for binding and activation of Tyro3 receptor and intracellular signalling.

Al Kafri N, Ahnstrom J, Teraz-Orosz A, Chaput L, Singh N, Villoutreix B Biochem Biophys Rep. 2022; 30:101263.

PMID: 35518197 PMC: 9065593. DOI: 10.1016/j.bbrep.2022.101263.

Laminin G1 residues of protein S mediate its TFPI cofactor function and are competitively regulated by C4BP.

Teraz-Orosz A, Gierula M, Petri A, Jones D, Keniyopoullos R, Folgado P Blood Adv. 2021; 6(2):704-715.

PMID: 34731882 PMC: 8791571. DOI: 10.1182/bloodadvances.2021005382.

Mode of induction of platelet-derived extracellular vesicles is a critical determinant of their phenotype and function.

Ferreira P, Bozbas E, Tannetta S, Alroqaiba N, Zhou R, Crawley J Sci Rep. 2020; 10(1):18061.

PMID: 33093473 PMC: 7582134. DOI: 10.1038/s41598-020-73005-3.

References

Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S . Protein S deficiency: a database of mutations--summary of the first update. Thromb Haemost. 2000; 84(5):918. View

Giri T, Garcia de Frutos P, Dahlback B . Protein S Thr103Asn mutation associated with type II deficiency reproduced in vitro and functionally characterised. Thromb Haemost. 2000; 84(3):413-9. View

Chang G, Aaldering L, Hackeng T, Reitsma P, Bertina R, Bouma B . Construction and characterization of thrombin-resistant variants of recombinant human protein S. Thromb Haemost. 1994; 72(5):693-7. View

Norstrom E, Steen M, Tran S, Dahlback B . Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va. J Biol Chem. 2003; 278(27):24904-11. DOI: 10.1074/jbc.M303829200. View

Stenflo J, Stenberg Y, Muranyi A . Calcium-binding EGF-like modules in coagulation proteinases: function of the calcium ion in module interactions. Biochim Biophys Acta. 2000; 1477(1-2):51-63. DOI: 10.1016/s0167-4838(99)00262-9. View

Heeb M, Schuck P, Xu X . Protein S multimers and monomers each have direct anticoagulant activity. J Thromb Haemost. 2006; 4(2):385-91. DOI: 10.1111/j.1538-7836.2006.01743.x. View

Rezende S, Razzari C, Simmonds R . In vitro high level protein S expression after modification of protein S cDNA. Thromb Haemost. 2003; 90(6):1214-5. View

Hackeng T, Sere K, Tans G, Rosing J . Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A. 2006; 103(9):3106-11. PMC: 1413864. DOI: 10.1073/pnas.0504240103. View

OBrien L, Mastri M, Fay P . Regulation of factor VIIIa by human activated protein C and protein S: inactivation of cofactor in the intrinsic factor Xase. Blood. 2000; 95(5):1714-20. View

10.

Rezende S, Lane D, Mille-Baker B, Samama M, Conard J, Simmonds R . Protein S Gla-domain mutations causing impaired Ca(2+)-induced phospholipid binding and severe functional protein S deficiency. Blood. 2002; 100(8):2812-9. DOI: 10.1182/blood-2002-03-0909. View

11.

Sere K, Rosing J, Hackeng T . Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance. Blood. 2004; 104(12):3624-30. DOI: 10.1182/blood-2004-03-1146. View

12.

Tsuda H, Urata M, Tsuda T, Wakiyama M, Iida H, Nakahara M . Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S. Thromb Res. 2002; 105(3):233-9. DOI: 10.1016/s0049-3848(02)00015-4. View

13.

Tran S, Dahlback B . Novel APC-cleavage sites in FVa provide insights into mechanisms of action of APC and its cofactor protein S. J Thromb Haemost. 2009; 8(1):129-36. DOI: 10.1111/j.1538-7836.2009.03657.x. View

14.

Gershagen S, Fernlund P, Lundwall A . A cDNA coding for human sex hormone binding globulin. Homology to vitamin K-dependent protein S. FEBS Lett. 1987; 220(1):129-35. DOI: 10.1016/0014-5793(87)80890-6. View

15.

Rosing J, Hoekema L, Nicolaes G, Thomassen M, Hemker H, Varadi K . Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995; 270(46):27852-8. DOI: 10.1074/jbc.270.46.27852. View

16.

Saller F, Brisset A, Tchaikovski S, Azevedo M, Chrast R, Fernandez J . Generation and phenotypic analysis of protein S-deficient mice. Blood. 2009; 114(11):2307-14. PMC: 2745849. DOI: 10.1182/blood-2009-03-209031. View

17.

He X, Shen L, Villoutreix B, Dahlback B . Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem. 1998; 273(42):27449-58. DOI: 10.1074/jbc.273.42.27449. View

18.

Tran S, Norstrom E, Dahlback B . Effects of prothrombin on the individual activated protein C-mediated cleavages of coagulation factor Va. J Biol Chem. 2008; 283(11):6648-55. DOI: 10.1074/jbc.M708036200. View

19.

Nelson R, VanDusen W, Friedman P, Long G . beta-Hydroxyaspartic acid and beta-hydroxyasparagine residues in recombinant human protein S are not required for anticoagulant cofactor activity or for binding to C4b-binding protein. J Biol Chem. 1991; 266(31):20586-9. View

20.

Persson K, Stenflo J, Linse S, Stenberg Y, Preston R, Lane D . Binding of calcium to anticoagulant protein S: role of the fourth EGF module. Biochemistry. 2006; 45(35):10682-9. PMC: 2242855. DOI: 10.1021/bi0601151. View